X-LINKED CHRONIC GRANULOMATOUS DISEASE
Clinical trials for X-LINKED CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new X-LINKED CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for X-LINKED CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Base Editing' to fix faulty immune cells
Disease control Recruiting nowThis study is testing a new gene-editing treatment for adults with a rare, inherited immune disorder called X-linked chronic granulomatous disease (X-CGD). Doctors will collect a patient's own blood stem cells, use a precise gene-editing tool called 'base editing' to try to fix t…
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
One-Time infusion aims to fix faulty immune cells
Disease control Recruiting nowThis early-stage study is testing a new one-time gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare disorder where the immune system can't fight off serious infections. The main goals are to see if the treatment is safe and if it can…
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC